Table 2 The univariate and multivariate analysis of post-operative LTL and clinicopathologic variables associated with OS in the resectable NSCLC patients.
From: Leukocyte telomere length serves as the novel prognostic biomarker for the resectable NSCLC
Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (≥ 61vs < 61) | 0.503 (0.182–1.390) | 0.185 | 0.427 (0.143–1.277) | 0.128 |
Smoke | 2.239 (0.892–5.619) | 0.086 | 1.986 (0.697–5.663) | 0.199 |
LTL (high group vs. low group) | 4.710 (1.566–14.163) | 0.006* | 5.629 (1.769–17.916) | 0.003* |
Stage (3 + 4 vs. 1 + 2) | 2.690 (1.096–6.602) | 0.031* | 1.909 (0.606–6.013) | 0.270 |
N stage (positive vs. negative) | 2.459 (0.976–6.196) | 0.056 | 2.496 (0.838–7.433) | 0.100 |
M stage (positive vs. negative) | 1.190 (0.273–5.181) | 0.816 | 0.742 (0.136–4.048) | 0.730 |
